Please use this identifier to cite or link to this item:
http://hdl.handle.net/10668/9984
Title: | Relationship between QT Interval Length and Arterial Stiffness in Systemic Lupus Erythematosus (SLE): A Cross-Sectional Case-Control Study. |
Authors: | Rivera-López, Ricardo Jiménez-Jáimez, Juan Sabio, José Mario Zamora-Pasadas, Mónica Vargas-Hitos, José Antonio Martínez-Bordonado, Josefina Navarrete-Navarrete, Nuria Fernández, Ricardo Rivera Sanchez-Cantalejo, E Jiménez-Alonso, Juan |
metadata.dc.subject.mesh: | Adult Carotid Intima-Media Thickness Case-Control Studies Cross-Sectional Studies Electrocardiography Female Follow-Up Studies Humans Long QT Syndrome Lupus Erythematosus, Systemic Male Middle Aged Prognosis Pulse Wave Analysis Risk Factors Vascular Stiffness |
Issue Date: | 11-Apr-2016 |
Abstract: | The QT interval on the electrocardiogram has been shown to be longer in patients with systemic lupus erythematosus (SLE) compared to that of the general population. The clinical significance of this finding is unknown. The aim of this study was to assess the relationship between QT interval and subclinical atherosclerosis, measured by carotid-femoral pulse-wave velocity. 93 patients with SLE and 109 healthy women with similar basal characteristics were studied. All patients underwent a 12- lead electrocardiogram, and corrected QT interval (QTc) was measured using the Bazett's formula. The presence of atherosclerosis was evaluated by carotid-femoral pulse-wave velocity. Clinical basal characteristics were similar in both groups. QTc interval was 415 ± 21.4 milliseconds in all patients, and 407 ± 19.1 milliseconds in the control group (p = 0.007). There was a positive correlation between QTc interval and carotid-femoral pulse-wave velocity (r = 0.235; p = 0.02) in patients with SLE. This association was independent of hypertension and age in a multivariate analysis. QTc interval measured by electrocardiogram is prolonged in SLE patients; it is related to subclinical atherosclerosis, measured by carotid-femoral pulse-wave velocity. This measure may help stratify risk in routine clinical practice and select the patients that might benefit from a more aggressive therapy in the prevention of cardiovascular events. |
URI: | http://hdl.handle.net/10668/9984 |
metadata.dc.identifier.doi: | 10.1371/journal.pone.0152291 |
Appears in Collections: | Producción 2020 |
Files in This Item:
File | Size | Format | |
---|---|---|---|
PMC4827799.pdf | 653,04 kB | Adobe PDF | View/Open |
This item is protected by original copyright |
This item is licensed under a Creative Commons License